Peptide sharing between SARS-CoV-2 and Bullous pemphigoid 180

A. Lucchese, D. Di Stasio, R. Borgia, M. Scivetti, M. Petruzzi

Article ID: 6311
Vol 36, Issue 2S4, 2022
DOI: https://doi.org/10.23812/j.biol.regul.homeost.agents.202236.2S4.3
Received: 9 May 2022; Accepted: 9 May 2022; Available online: 9 May 2022; Issue release: 9 May 2022

Abstract

Bullous pemphigoid (BP) has been repeatedly reported to occur following exposure to the severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study analyzes the molecular mimicrybetween the 180 kDa bullous pemphigoid antigen 2 (BP180) and the SARS-CoV-2 proteome to further ourunderstanding of the molecular link between the BP and the SARS-CoV-2 infection. Results indicate a highdegree of molecular mimicry between BP180, SARS-CoV-2, hCoV-229E and hCoV-NL63.


Keywords

Bullous pemphigoid;BP180;SARS-Cov-2;Covid-19;autoimmunity;molecular mimicry;cross-reactivity


References

Supporting Agencies



Copyright (c) 2022 A. Lucchese, D. Di Stasio, R. Borgia, M. Scivetti, M. Petruzzi




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).